Charles Campbell Roberts

Charles Campbell Roberts serves as the Chief Investment Strategist at ARK Investment Management LLC, where Charles leads private investments focusing on disruptive technologies. As a co-founder of Freenome, Roberts contributes to the application of machine learning in cancer detection, securing significant funding for the initiative. Additionally, Roberts co-founded Relation Therapeutics, aiming to explore new drug targets for degenerative diseases, and provides advisory support to various organizations, including NewLimit and Elevance Health. Roberts' extensive entrepreneurial background includes co-founding multiple biotech firms, such as Agalimmune and Yourgene Health, which have made significant advancements in cancer immunotherapy and prenatal testing, respectively. Educational qualifications include an MSc in Experimental Therapeutics from the University of Oxford and a BSc (Hons.) in Psychology from UCL.